+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global RNAi Drug Delivery Market 2023-2027

  • PDF Icon

    Report

  • 175 Pages
  • June 2023
  • Region: Global
  • TechNavio
  • ID: 5850061
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The RNAi drug delivery market is forecasted to grow by USD 109.73 bn during 2022-2027, accelerating at a CAGR of 20.83% during the forecast period. The report on the RNAi drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high target affinity and specificity of RNAi therapeutics, increasing research activities in pharmaceutical and biotechnology sectors, and increasing prevalence of neurological disorders.

The RNAi drug delivery market is segmented as below:

By Technology

  • Nanoparticle drug delivery
  • Pulmonary drug delivery
  • Nucleic acid drug delivery
  • Aptamer drug delivery

By Application

  • Infectious diseases
  • Oncology
  • Cardiology
  • Neurology
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing r and d for RNAi therapy by vendors as one of the prime reasons driving the RNAi drug delivery market growth during the next few years. Also, increasing focus on RNAi drugs for multiple therapy areas and significant scientific progress in RNAi approach will lead to sizable demand in the market.

The report on the RNAi drug delivery market covers the following areas:

  • RNAi drug delivery market sizing
  • RNAi drug delivery market forecast
  • RNAi drug delivery market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading RNAi drug delivery market vendors that include Alnylam Pharmaceuticals Inc., Arbutus Biopharma Corp., Arrowhead Pharmaceuticals Inc., Bayer AG, Benitec Biopharma Inc., BioNTech SE, Bristol Myers Squibb Co., CureVac AG, e therapeutics plc, F. Hoffmann La Roche Ltd., Novartis AG, Novo Nordisk AS, Phio Pharmaceuticals, Sanofi, Silence Therapeutics plc, Silenseed Inc., siRNAgen Therapeutics Corp., Sirnaomics Inc., Sylentis S.A., Thermo Fisher Scientific Inc., and TransCode Therapeutics Inc.. Also, the RNAi drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global RNAi drug delivery market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global rnai drug delivery market 2017 - 2021 ($ billion)
4.2 Technology Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Technology Segment 2017 - 2021 ($ billion)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Technology
6.1 Market segments
Exhibit 30: Chart on Technology - Market share 2022-2027 (%)
Exhibit 31: Data Table on Technology - Market share 2022-2027 (%)
6.2 Comparison by Technology
Exhibit 32: Chart on Comparison by Technology
Exhibit 33: Data Table on Comparison by Technology
6.3 Nanoparticle drug delivery - Market size and forecast 2022-2027
Exhibit 34: Chart on Nanoparticle drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Nanoparticle drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Nanoparticle drug delivery - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Nanoparticle drug delivery - Year-over-year growth 2022-2027 (%)
6.4 Pulmonary drug delivery - Market size and forecast 2022-2027
Exhibit 38: Chart on Pulmonary drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Pulmonary drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Pulmonary drug delivery - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Pulmonary drug delivery - Year-over-year growth 2022-2027 (%)
6.5 Nucleic acid drug delivery - Market size and forecast 2022-2027
Exhibit 42: Chart on Nucleic acid drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Nucleic acid drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Nucleic acid drug delivery - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Nucleic acid drug delivery - Year-over-year growth 2022-2027 (%)
6.6 Aptamer drug delivery - Market size and forecast 2022-2027
Exhibit 46: Chart on Aptamer drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Aptamer drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Aptamer drug delivery - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Aptamer drug delivery - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Technology
Exhibit 50: Market opportunity by Technology ($ billion)
Exhibit 51: Data Table on Market opportunity by Technology ($ billion)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 52: Chart on Application - Market share 2022-2027 (%)
Exhibit 53: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 54: Chart on Comparison by Application
Exhibit 55: Data Table on Comparison by Application
7.3 Infectious diseases - Market size and forecast 2022-2027
Exhibit 56: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
7.4 Oncology - Market size and forecast 2022-2027
Exhibit 60: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
7.5 Cardiology - Market size and forecast 2022-2027
Exhibit 64: Chart on Cardiology - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Cardiology - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
7.6 Neurology - Market size and forecast 2022-2027
Exhibit 68: Chart on Neurology - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on Neurology - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
7.7 Others - Market size and forecast 2022-2027
Exhibit 72: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 75: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Application
Exhibit 76: Market opportunity by Application ($ billion)
Exhibit 77: Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 81: Chart on Geographic comparison
Exhibit 82: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 115: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 116: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 117: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 121: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 123: Overview on factors of disruption
11.4 Industry risks
Exhibit 124: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 125: Vendors covered
12.2 Market positioning of vendors
Exhibit 126: Matrix on vendor position and classification
12.3 Alnylam Pharmaceuticals Inc.
Exhibit 127: Alnylam Pharmaceuticals Inc. - Overview
Exhibit 128: Alnylam Pharmaceuticals Inc. - Product/Service
Exhibit 129: Alnylam Pharmaceuticals Inc. - Key news
Exhibit 130: Alnylam Pharmaceuticals Inc. - Key offerings
12.4 Arbutus Biopharma Corp.
Exhibit 131: Arbutus Biopharma Corp. - Overview
Exhibit 132: Arbutus Biopharma Corp. - Product/Service
Exhibit 133: Arbutus Biopharma Corp. - Key offerings
12.5 Arrowhead Pharmaceuticals Inc.
Exhibit 134: Arrowhead Pharmaceuticals Inc. - Overview
Exhibit 135: Arrowhead Pharmaceuticals Inc. - Business segments
Exhibit 136: Arrowhead Pharmaceuticals Inc. - Key offerings
Exhibit 137: Arrowhead Pharmaceuticals Inc. - Segment focus
12.6 Bayer AG
Exhibit 138: Bayer AG - Overview
Exhibit 139: Bayer AG - Business segments
Exhibit 140: Bayer AG - Key news
Exhibit 141: Bayer AG - Key offerings
Exhibit 142: Bayer AG - Segment focus
12.7 BioNTech SE
Exhibit 143: BioNTech SE - Overview
Exhibit 144: BioNTech SE - Product/Service
Exhibit 145: BioNTech SE - Key offerings
12.8 Bristol Myers Squibb Co.
Exhibit 146: Bristol Myers Squibb Co. - Overview
Exhibit 147: Bristol Myers Squibb Co. - Product/Service
Exhibit 148: Bristol Myers Squibb Co. - Key news
Exhibit 149: Bristol Myers Squibb Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Novartis AG
Exhibit 155: Novartis AG - Overview
Exhibit 156: Novartis AG - Business segments
Exhibit 157: Novartis AG - Key offerings
Exhibit 158: Novartis AG - Segment focus
12.11 Novo Nordisk AS
Exhibit 159: Novo Nordisk AS - Overview
Exhibit 160: Novo Nordisk AS - Business segments
Exhibit 161: Novo Nordisk AS - Key offerings
Exhibit 162: Novo Nordisk AS - Segment focus
12.12 Phio Pharmaceuticals
Exhibit 163: Phio Pharmaceuticals - Overview
Exhibit 164: Phio Pharmaceuticals - Product/Service
Exhibit 165: Phio Pharmaceuticals - Key offerings
12.13 Sanofi
Exhibit 166: Sanofi - Overview
Exhibit 167: Sanofi - Business segments
Exhibit 168: Sanofi - Key news
Exhibit 169: Sanofi - Key offerings
Exhibit 170: Sanofi - Segment focus
12.14 Silence Therapeutics plc
Exhibit 171: Silence Therapeutics plc - Overview
Exhibit 172: Silence Therapeutics plc - Product/Service
Exhibit 173: Silence Therapeutics plc - Key offerings
12.15 Sirnaomics Inc.
Exhibit 174: Sirnaomics Inc. - Overview
Exhibit 175: Sirnaomics Inc. - Product/Service
Exhibit 176: Sirnaomics Inc. - Key offerings
12.16 Sylentis S.A.
Exhibit 177: Sylentis S.A. - Overview
Exhibit 178: Sylentis S.A. - Product/Service
Exhibit 179: Sylentis S.A. - Key offerings
12.17 Thermo Fisher Scientific Inc.
Exhibit 180: Thermo Fisher Scientific Inc. - Overview
Exhibit 181: Thermo Fisher Scientific Inc. - Business segments
Exhibit 182: Thermo Fisher Scientific Inc. - Key news
Exhibit 183: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 184: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 185: Inclusions checklist
Exhibit 186: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 187: Currency conversion rates for US$
13.4 Research methodology
Exhibit 188: Research methodology
Exhibit 189: Validation techniques employed for market sizing
Exhibit 190: Information sources
13.5 List of abbreviations
Exhibit 191: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global rnai drug delivery market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - Technology Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Technology - Market share 2022-2027 (%)
Exhibits 31: Data Table on Technology - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Technology
Exhibits 33: Data Table on Comparison by Technology
Exhibits 34: Chart on Nanoparticle drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on Nanoparticle drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on Nanoparticle drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Nanoparticle drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Pulmonary drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on Pulmonary drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on Pulmonary drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Pulmonary drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Nucleic acid drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits 43: Data Table on Nucleic acid drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits 44: Chart on Nucleic acid drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Nucleic acid drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Aptamer drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits 47: Data Table on Aptamer drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits 48: Chart on Aptamer drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Aptamer drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits 50: Market opportunity by Technology ($ billion)
Exhibits 51: Data Table on Market opportunity by Technology ($ billion)
Exhibits 52: Chart on Application - Market share 2022-2027 (%)
Exhibits 53: Data Table on Application - Market share 2022-2027 (%)
Exhibits 54: Chart on Comparison by Application
Exhibits 55: Data Table on Comparison by Application
Exhibits 56: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits 57: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits 58: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits 61: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits 62: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Cardiology - Market size and forecast 2022-2027 ($ billion)
Exhibits 65: Data Table on Cardiology - Market size and forecast 2022-2027 ($ billion)
Exhibits 66: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibits 68: Chart on Neurology - Market size and forecast 2022-2027 ($ billion)
Exhibits 69: Data Table on Neurology - Market size and forecast 2022-2027 ($ billion)
Exhibits 70: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits 71: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits 72: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 73: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 74: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 75: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 76: Market opportunity by Application ($ billion)
Exhibits 77: Data Table on Market opportunity by Application ($ billion)
Exhibits 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 81: Chart on Geographic comparison
Exhibits 82: Data Table on Geographic comparison
Exhibits 83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 104: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 111: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 112: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 114: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 115: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 116: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 117: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 118: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 119: Market opportunity By Geographical Landscape ($ billion)
Exhibits 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 121: Impact of drivers and challenges in 2022 and 2027
Exhibits 122: Overview on Criticality of inputs and Factors of differentiation
Exhibits 123: Overview on factors of disruption
Exhibits 124: Impact of key risks on business
Exhibits 125: Vendors covered
Exhibits 126: Matrix on vendor position and classification
Exhibits 127: Alnylam Pharmaceuticals Inc. - Overview
Exhibits 128: Alnylam Pharmaceuticals Inc. - Product/Service
Exhibits 129: Alnylam Pharmaceuticals Inc. - Key news
Exhibits 130: Alnylam Pharmaceuticals Inc. - Key offerings
Exhibits 131: Arbutus Biopharma Corp. - Overview
Exhibits 132: Arbutus Biopharma Corp. - Product/Service
Exhibits 133: Arbutus Biopharma Corp. - Key offerings
Exhibits 134: Arrowhead Pharmaceuticals Inc. - Overview
Exhibits 135: Arrowhead Pharmaceuticals Inc. - Business segments
Exhibits 136: Arrowhead Pharmaceuticals Inc. - Key offerings
Exhibits 137: Arrowhead Pharmaceuticals Inc. - Segment focus
Exhibits 138: Bayer AG - Overview
Exhibits 139: Bayer AG - Business segments
Exhibits 140: Bayer AG - Key news
Exhibits 141: Bayer AG - Key offerings
Exhibits 142: Bayer AG - Segment focus
Exhibits 143: BioNTech SE - Overview
Exhibits 144: BioNTech SE - Product/Service
Exhibits 145: BioNTech SE - Key offerings
Exhibits 146: Bristol Myers Squibb Co. - Overview
Exhibits 147: Bristol Myers Squibb Co. - Product/Service
Exhibits 148: Bristol Myers Squibb Co. - Key news
Exhibits 149: Bristol Myers Squibb Co. - Key offerings
Exhibits 150: F. Hoffmann La Roche Ltd. - Overview
Exhibits 151: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 152: F. Hoffmann La Roche Ltd. - Key news
Exhibits 153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 154: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 155: Novartis AG - Overview
Exhibits 156: Novartis AG - Business segments
Exhibits 157: Novartis AG - Key offerings
Exhibits 158: Novartis AG - Segment focus
Exhibits 159: Novo Nordisk AS - Overview
Exhibits 160: Novo Nordisk AS - Business segments
Exhibits 161: Novo Nordisk AS - Key offerings
Exhibits 162: Novo Nordisk AS - Segment focus
Exhibits 163: Phio Pharmaceuticals - Overview
Exhibits 164: Phio Pharmaceuticals - Product/Service
Exhibits 165: Phio Pharmaceuticals - Key offerings
Exhibits 166: Sanofi - Overview
Exhibits 167: Sanofi - Business segments
Exhibits 168: Sanofi - Key news
Exhibits 169: Sanofi - Key offerings
Exhibits 170: Sanofi - Segment focus
Exhibits 171: Silence Therapeutics plc - Overview
Exhibits 172: Silence Therapeutics plc - Product/Service
Exhibits 173: Silence Therapeutics plc - Key offerings
Exhibits 174: Sirnaomics Inc. - Overview
Exhibits 175: Sirnaomics Inc. - Product/Service
Exhibits 176: Sirnaomics Inc. - Key offerings
Exhibits 177: Sylentis S.A. - Overview
Exhibits 178: Sylentis S.A. - Product/Service
Exhibits 179: Sylentis S.A. - Key offerings
Exhibits 180: Thermo Fisher Scientific Inc. - Overview
Exhibits 181: Thermo Fisher Scientific Inc. - Business segments
Exhibits 182: Thermo Fisher Scientific Inc. - Key news
Exhibits 183: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 184: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 185: Inclusions checklist
Exhibits 186: Exclusions checklist
Exhibits 187: Currency conversion rates for US$
Exhibits 188: Research methodology
Exhibits 189: Validation techniques employed for market sizing
Exhibits 190: Information sources
Exhibits 191: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global rnai drug delivery market: Alnylam Pharmaceuticals Inc., Arbutus Biopharma Corp., Arrowhead Pharmaceuticals Inc., Bayer AG, Benitec Biopharma Inc., BioNTech SE, Bristol Myers Squibb Co., CureVac AG, e therapeutics plc, F. Hoffmann La Roche Ltd., Novartis AG, Novo Nordisk AS, Phio Pharmaceuticals, Sanofi, Silence Therapeutics plc, Silenseed Inc., siRNAgen Therapeutics Corp., Sirnaomics Inc., Sylentis S.A., Thermo Fisher Scientific Inc., and TransCode Therapeutics Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing R and D for RNAi therapy by vendors.'

According to the report, one of the major drivers for this market is the high target affinity and specificity of RNAi therapeutics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alnylam Pharmaceuticals Inc.
  • Arbutus Biopharma Corp.
  • Arrowhead Pharmaceuticals Inc.
  • Bayer AG
  • Benitec Biopharma Inc.
  • BioNTech SE
  • Bristol Myers Squibb Co.
  • CureVac AG
  • e therapeutics plc
  • F. Hoffmann La Roche Ltd.
  • Novartis AG
  • Novo Nordisk AS
  • Phio Pharmaceuticals
  • Sanofi
  • Silence Therapeutics plc
  • Silenseed Inc.
  • siRNAgen Therapeutics Corp.
  • Sirnaomics Inc.
  • Sylentis S.A.
  • Thermo Fisher Scientific Inc.
  • TransCode Therapeutics Inc.

Related Topics

Related Reports

RNAi Drug Delivery: Technologies and Global Markets - Product Image

RNAi Drug Delivery: Technologies and Global Markets

  • Report
  • 141 Pages
  • Global
From
Antisense & RNAi Therapeutics Global Market Report 2024 - Product Image

Antisense & RNAi Therapeutics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
RNAi Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

RNAi Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 180 Pages
  • Global
From
Global RNA-interference (RNAi) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global RNA-interference (RNAi) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 114 Pages
  • Global
From
Antisense & RNAi Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Antisense & RNAi Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.